EUVIMEDEUVIMED entdecken
Open Access

Ketone body β-hydroxybutyrate-mediated histone β-hydroxybutyrylation upregulates lipolysis and attenuates metabolic syndrome

Sachin Aryal iD, Blair Mell, Ishan Manandhar iD, Beng San Yeoh iD, Xue Mei, Oluwatosin Mautin Akinola, Wisdom Ahlidja, Bina Joe iD

American Journal of Physiology-Cell Physiology · 2025

DOI: 10.1152/ajpcell.00453.2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Sachin Aryal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, College of Medicine and Life Sciences, University of Toled…. Hauptthemen laut MEDLINE: 3-Hydroxybutyric Acid, Metabolic Syndrome, Lipolysis, Histones. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), American Heart Association (AHA), NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This is the first study to demonstrate that exogenous β-hydroxybutyrate supplementation attenuates metabolic syndrome (MetS) and identifies histone β-hydroxybutyrylation-mediated chromatin remodeling as one of the mechanisms to upregulate the transcription of the lipid catabolic genes, Hmgcs2, Cyp2d4, Cyp2e1, and Acaa1b. Our work constitutes a strong foundation for the use of 1,3-butanediol as an alternative epigenetic therapeutic for individuals who are physically unable to achieve the MetS lowering benefits of lifestyle modifications such as exercise and intermittent fasting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

3-Hydroxybutyric AcidMetabolic SyndromeLipolysisHistonesKetone BodiesAnimalsMaleRatsUp-RegulationEpigenesis, GeneticLiver

Stichwörter der Autor:innen

chromatin remodelingepigeneticsexerciseketonemetabolic syndrome

Substanzen

3-Hydroxybutyric AcidHistonesKetone Bodies

Autor:innen und Institutionen

  • Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, College of Medicine and Life Sciences, University of Toledo, Toledo, Ohio, United States.
  • College of Pharmacy, North Sichuan Medical College, Nanchong, China.

ORCID-Profile: Sachin Aryal, Ishan Manandhar, Beng San Yeoh, Bina Joe

Förderung

  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  • American Heart Association (AHA)
  • NHLBI NIH HHS
  • American Liver Foundation (ALF)

Zitieren

APA

Aryal, S., Mell, B., Manandhar, I., Yeoh, B. S., Mei, X., Akinola, O. M., Ahlidja, W., & Joe, B. (2025). Ketone body β-hydroxybutyrate-mediated histone β-hydroxybutyrylation upregulates lipolysis and attenuates metabolic syndrome. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00453.2025

Vancouver

Aryal S, Mell B, Manandhar I, Yeoh BS, Mei X, Akinola OM, et al. Ketone body β-hydroxybutyrate-mediated histone β-hydroxybutyrylation upregulates lipolysis and attenuates metabolic syndrome. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00453.2025

BibTeX
@article{Aryal2025,
  author = {Aryal, Sachin and Mell, Blair and Manandhar, Ishan and Yeoh, Beng San and Mei, Xue and Akinola, Oluwatosin Mautin and Ahlidja, Wisdom and Joe, Bina},
  title = {Ketone body β-hydroxybutyrate-mediated histone β-hydroxybutyrylation upregulates lipolysis and attenuates metabolic syndrome},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2025},
  doi = {10.1152/ajpcell.00453.2025}
}
Kostenlos starten →